Top Biotech Halozyme Undercuts Its Breakout On Bad Medicare News
Top Biotech Halozyme Undercuts Its Breakout On Bad Medicare News · Investor's Business Daily

In This Article:

Halozyme Therapeutics shares tumbled Tuesday on a new Medicare approach to price negotiations for drugs that use additive products.